Why do eyelashes fall out

Overview

Eyelash loss, medically termed madarosis, has been documented since ancient times, with Egyptian medical texts from 1550 BCE describing treatments for hair loss. Historically, cultures worldwide have valued eyelashes for both protective and aesthetic purposes. In the 20th century, scientific understanding advanced significantly, with the 1950s marking key discoveries about hair growth cycles. Today, eyelash health represents a multi-billion dollar industry, with the global eyelash enhancer market projected to reach $1.5 billion by 2025. The average person has 90-150 lashes on the upper eyelid and 70-80 on the lower, with variations across ethnicities. Research shows Asian individuals typically have fewer but thicker lashes compared to Caucasian counterparts. Modern concerns have expanded beyond medical conditions to include cosmetic damage from popular treatments, with studies indicating 78% of eyelash extension users experience some natural lash damage.

How It Works

Eyelash growth follows a three-phase cycle: anagen (active growth, 30-45 days), catagen (transition, 2-3 weeks), and telogen (resting, 100+ days before shedding). Each follicle operates independently, preventing simultaneous loss. Natural shedding occurs when new hairs push out old ones during the anagen phase restart. Pathological loss mechanisms vary: autoimmune conditions like alopecia areata cause inflammatory attacks on follicles, while thyroid disorders disrupt growth cycles through hormonal imbalances. Physical damage occurs when excessive tension from extensions or rubbing exceeds the lash's tensile strength of approximately 1/10 gram. Chemical damage from mascara or adhesives can degrade the keratin structure. Medications like chemotherapy drugs interrupt the anagen phase, while nutritional deficiencies (particularly iron, biotin, or protein) impair follicle function. Stress-induced telogen effluvium shifts hairs prematurely to shedding phase.

Why It Matters

Eyelash preservation matters medically as lashes provide crucial eye protection, filtering 50% of airborne particles and reducing evaporation by 25%. Their loss increases risks of infections, dry eye syndrome, and corneal damage. Psychologically, studies show eyelash loss reduces perceived attractiveness by 40% and can trigger social anxiety. Economically, the condition drives significant healthcare spending, with Americans spending over $200 million annually on prescription lash treatments. Cosmetically, it has fueled a $1.9 billion eyelash product industry. Research implications are substantial, as lash follicles serve as accessible models for studying hair biology, contributing to broader alopecia treatments. Legally, inadequate warning about lash extension risks has prompted consumer protection lawsuits, while medically, distinguishing normal shedding from pathological loss enables early detection of systemic diseases like lupus or thyroid disorders.